Blue Owl Capital Sees Unusually High Options Volume (NYSE:OWL)

Blue Owl Capital Inc. (NYSE:OWL) saw unusually large options trading on Monday. Stock investors bought 50,814 put options on the company. This represents an increase of approximately 32% compared to the typical daily volume of 38,456 put options.

Blue Owl Capital Stock Performance

NYSE OWL traded down $0.08 on Monday, reaching $9.82. The company’s stock had a trading volume of 31,127,955 shares, compared to its average volume of 28,280,738. Blue Owl Capital has a twelve month low of $9.54 and a twelve month high of $21.88. The firm’s 50 day moving average is $13.43 and its two-hundred day moving average is $15.41. The stock has a market cap of $15.26 billion, a PE ratio of 98.16, a PEG ratio of 0.82 and a beta of 1.15.

Blue Owl Capital (NYSE:OWL) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The business had revenue of $701.47 million during the quarter, compared to the consensus estimate of $712.75 million. Blue Owl Capital had a net margin of 2.75% and a return on equity of 20.93%. Equities research analysts anticipate that Blue Owl Capital will post 0.92 EPS for the current fiscal year.

Blue Owl Capital Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 20th were paid a dividend of $0.225 per share. The ex-dividend date was Friday, February 20th. This represents a $0.90 annualized dividend and a yield of 9.2%. Blue Owl Capital’s dividend payout ratio is presently 900.00%.

Analyst Ratings Changes

OWL has been the subject of a number of analyst reports. The Goldman Sachs Group decreased their price objective on shares of Blue Owl Capital from $16.25 to $14.00 and set a “neutral” rating for the company in a research report on Friday, February 6th. Zacks Research cut shares of Blue Owl Capital from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 27th. Evercore set a $14.00 target price on Blue Owl Capital in a report on Friday, February 6th. TD Cowen restated a “buy” rating on shares of Blue Owl Capital in a research note on Wednesday, January 14th. Finally, Wolfe Research set a $20.00 price target on shares of Blue Owl Capital in a research report on Wednesday, January 7th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Blue Owl Capital currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.00.

Hedge Funds Weigh In On Blue Owl Capital

Hedge funds and other institutional investors have recently modified their holdings of the stock. Royal Bank of Canada increased its holdings in shares of Blue Owl Capital by 50.0% in the first quarter. Royal Bank of Canada now owns 397,990 shares of the company’s stock valued at $7,976,000 after purchasing an additional 132,637 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in shares of Blue Owl Capital by 528.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 7,218 shares of the company’s stock worth $139,000 after buying an additional 6,070 shares during the last quarter. Vestmark Advisory Solutions Inc. bought a new stake in Blue Owl Capital during the second quarter worth $1,235,000. Wedbush Securities Inc. boosted its stake in shares of Blue Owl Capital by 6.7% during the 2nd quarter. Wedbush Securities Inc. now owns 69,573 shares of the company’s stock worth $1,336,000 after acquiring an additional 4,361 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new position in Blue Owl Capital in the 2nd quarter valued at about $963,000. Institutional investors own 35.85% of the company’s stock.

About Blue Owl Capital

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.